Baxter International (NYSE:BAX) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Over the past year, Baxter has outperformed the broader industry in terms of price performance. The company's impressive performance at the hospital products and renal segments hold promise. Baxter launched the oXIRIS set for continuous renal replacement therapy (CRRT) and sepsis management protocols in select markets of Europe, Middle East and Africa recently. Further, the recent launch of DeviceVue, a comprehensive asset tracking solution available exclusively to hospitals, boosts the company’s product portfolio. On the flipside, foreign currency headwinds, intensifying competition and lackluster sales growth have been dampening Baxter’s performance since long. Generic competition for cyclophosphamide is an added headwind. Furthermore, the recent hurricanes are expected to dent the company’s results in the near term. Baxter stock looks a tad expensive at the moment.”
BlackBerry (NYSE:BB) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $13.00 target price on the stock. According to Zacks, “Shares of BlackBerry outperformed its industry in 2017. The stock rallied 62.2% compared with its industry's gain of only 10.9%. Ushering in further good news, the company's deal with Baidu on a self-driving car project pleased investors. Consequently, the stock appreciated significantly following the news. BlackBerry’s decision to focus exclusively on software business seems to be paying off as robust software sales are aiding the company immensely. In fact, software and service revenues are estimated to rise between 10% and 15% in fiscal 2018. Growth of its cybersecurity business is also a huge positive. BlackBerry’s projection of its free cash flow in fiscal 2018 is also encouraging. However, the unfavorable verdict in the Nokia case is disappointing. Charges pertaining to the issue hurt the bottom line in the fiscal fourth quarter.”
C.H. Robinson Worldwide (NASDAQ:CHRW) was upgraded by analysts at Citigroup Inc from a neutral rating to a buy rating.
CVS Health (NYSE:CVS) was upgraded by analysts at Raymond James Financial, Inc. from an outperform rating to a strong-buy rating. The firm currently has $90.00 price target on the stock. They noted that the move was a valuation call. The analysts noted that the move was a valuation call.
Hancock (NASDAQ:HBHC) was upgraded by analysts at Sandler O’Neill from a hold rating to a buy rating.
Lincoln Electric (NASDAQ:LECO) was upgraded by analysts at Oppenheimer Holdings Inc. from a market perform rating to an outperform rating. Oppenheimer Holdings Inc. currently has $105.00 price target on the stock.
Lennar (NYSE:LEN) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Lennar is one of the best-positioned homebuilders to capitalize on the housing recovery, courtesy of the diverse revenue mix, steady top-line performance, above-average order growth and improving SG&A leverage. Moreover, Lennar has agreed to take over CalAtlantic Group in a deal worth $9.3 billion. The combined entity will have a footprint touching approximately 50% of the U.S. population and is expected to generate meaningful cost savings. However, labor shortage along with rising land and labor costs pose a threat to the company’s margins. In the first nine months of fiscal 2017, Lennar’s gross margin on home sales decreased 90 bps year over year, due to an increase in construction and land costs per home. Also, Lennar shares have underperformed its industry in the last one year. Earnings estimates for the fourth quarter and the fiscal 2017 have remained stable ahead of the earnings release.”
Mastercard (NYSE:MA) was upgraded by analysts at Mizuho from a neutral rating to a buy rating.
Impinj (NASDAQ:PI) was upgraded by analysts at Zacks Investment Research from a strong sell rating to a hold rating. According to Zacks, “Impinj, Inc. is a provider of referral and information network radio frequency identification solutions to the retail, pharmaceutical, healthcare, food and beverage and other industries. The company’s products include Indy Reader Chips which consists of integrated radio chips and supporting SDKs; Monza Tag Chips, which deliver memory options and extended features to RFID tags and Speedway fixed RFID readers and antennas for RFID-based information. Impinj, Inc. is based in Seattle, Washington. “
PJT Partners (NYSE:PJT) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “PJT Partners Inc. is a financial advisory firm. The Company offers strategic advisory, restructuring and reorganization, fund placement and funds advisory services to corporations, financial sponsors, institutional investors and governments. PJT Partners Inc. is based in NEW YORK, United States. “
ePlus (NASDAQ:PLUS) was upgraded by analysts at Zacks Investment Research from a strong sell rating to a hold rating. According to Zacks, “ePlus inc. is a leading provider of technology solutions. ePlus enables organizations to optimize their IT infrastructure and supply chain processes by delivering world-class IT products from top manufacturers, professional services, flexible lease financing, proprietary software, and patented business methods. With the highest certifications from top technology partners and expertise in key technologies from data center to security, cloud, and collaboration, ePlus transforms IT from a cost center to a business enabler. “
Pioneer Pwr Sol Cmn (OTCMKTS:PPSI) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Pioneer Power Solutions, Inc. is specialty manufacturer of electrical transmission and distribution equipment. The company provide solutions in the utility, industrial and commercial segments of the electrical transmission and distribution industry. It operates primarily in the U.S., Canada and Mexico. Pioneer Power Solutions, Inc. is headquartered in Fort Lee, New Jersey. “
PRA Health Sciences (NASDAQ:PRAH) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $102.00 target price on the stock. According to Zacks, “PRA Health Sciences, Inc. operates as a global contract research organizations providing outsourced clinical development services to the biotechnology and pharmaceutical industries. It offers therapeutic services in the areas of cardio-metabolic, biosimilars, infectious diseases, immunology, neurology and psychiatry, oncology and hematology, rare diseases, and respiratory needs. The Company engages in bioanalytical laboratory, clinical pharmacology, clinical development, strategic solutions, post marketing research, clinical informatics, clinical diagnostics, and safety and risk management activities. PRA Health Sciences, Inc. is based in Raleigh, North Carolina. “
Perficient (NASDAQ:PRFT) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $21.00 price target on the stock. According to Zacks, “Perficient is the leading digital transformation consulting firm with unparalleled information technology, management consulting, and creative capabilities, Perficient and its Perficient Digital agency deliver vision, execution, and value with outstanding digital experience, business optimization, and industry solutions. Their work enables clients to improve productivity and competitiveness; grow and strengthen relationships with customers, suppliers, and partners; and reduce costs. Its solutions include big data and analytics, technology platform implementations, commerce, enterprise content management, portals and collaboration, management consulting, custom applications, business integration, business process management, and customer relationship management, among others. “
ParkerVision (NASDAQ:PRKR) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “ParkerVision, Inc. operates two segments – the Video Products Division and the Wireless Technology Division. The Video Division is engaged in the design, development and marketing of automated video camera control systems, marketed under the tradename CameraMan and automated production systems, marketed under the tradename PVTV Studio. The Wireless Division is engaged in the development and initial commercialization of its Direct2Data, or D2D, technology. “
Proto Labs (NYSE:PRLB) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $115.00 target price on the stock. According to Zacks, “Proto Labs, Inc. is an online and technology-enabled quick-turn manufacturer of custom parts for prototyping and short-run production. It produces CNC machined and injection molded plastic parts. Proto Labs targets their services to product developers who use three-dimensional computer-aided design to develop products across a diverse range of end-markets. The Company has locations in the United States, the United Kingdom, Germany, Japan, Italy, France, and Spain. Proto Labs, Inc. is headquartered in Maple Plain, Minnesota. “
Taylor Morrison Home (NYSE:TMHC) was upgraded by analysts at Susquehanna Bancshares Inc from a neutral rating to a positive rating.
Wells Fargo & Co (NYSE:WFC) was upgraded by analysts at Goldman Sachs Group Inc from a buy rating to a conviction-buy rating. They currently have $63.00 price target on the stock.
Wix.Com (NASDAQ:WIX) was upgraded by analysts at Raymond James Financial, Inc. from a market perform rating to a strong-buy rating. They currently have $74.00 price target on the stock.
Receive News & Ratings for Baxter International Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International Inc and related companies with MarketBeat.com's FREE daily email newsletter.